Aurora Cannabis Inc. (TSX: ACB)
Health Care · Pharmaceuticals · CA
CA$5.54
+2.40% today · -25.4% 1Y
Aurora Cannabis Inc. (TSX: ACB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $254.85M and employs 1,028 people.
Over the last twelve months the share price has lost 25.4%, trading between 3.59 and 9.33.
Tweenvest scores Aurora Cannabis Inc. across four factors: quality 54/100, value 79/100, growth 60/100. Its strongest factor is value.
ACB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $254.85M
- Revenue (TTM)
- $221.16M
- P/E
- —
- EPS
- -2.07
- Dividend yield
- —
- Beta (5Y)
- 1.34
- 52-week high
- CA$9.33
- 52-week low
- CA$3.59
- Avg volume (3M)
- —
- Shares outstanding
- 64.86M
- Employees
- 1,028
- Next earnings
- —
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is a Canada-based firm specializing in the cultivation, processing, and global distribution of cannabis and its various derivative products. The company's operations encompass a broad spectrum of the cannabis industry, from facility engineering and design to genetic research, production, and the development of new products, all supported by extensive wholesale and retail networks. For medical users, Aurora offers diverse strains of dried cannabis, oils, capsules, and topical kits. Additionally, it markets a range of accessories, including vaporizers, consumable parts, herb mills (specifically for CanniMed products), grinders, and lockable vaporizer containers. The company is committed to advancing medical cannabis, with ongoing development across oral, topical, edible, and inhalable product categories. Aurora also provides key services such as patient counseling, design and construction assistance, and comprehensive analytical product testing for cannabis, alongside operating CanvasRX, a network dedicated to cannabis counseling and outreach. Its expansive brand family includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The corporate headquarters are located in Edmonton, Canada.
- ISIN
- CA05156X8504
- Founded
- 2013
- Listed since
- Oct 5, 2016
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.